Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.06.28
关于筹划发行股份购买资产的停牌进展公告
2017.06.28
关于公司与汇丰银行交叉货币掉期交易平仓的公告
2017.06.24
关于签订《募集资金三方监管协议》的公告
2017.06.21
2016年年度权益分派实施公告
2017.06.21
关于筹划发行股份购买资产停牌进展及继续停牌公告
2017.06.21
第四届董事会第二次会议决议公告
2017.06.20
2016年公司债券受托管理事务报告（2016年度）
2017.06.14
关于筹划发行股份购买资产的停牌进展公告
2017.06.08
关于更换持续督导机构的公告
2017.06.08
关于名称变更的补充公告
第一页
上一页
77
78
79
80
81
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
